These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29614442)

  • 101. Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study.
    Abdel-Razeq H; Sharaf B; Bani Hani H; Abu Hijlih R; Alkyam M; Al-Azzam K; Elemian S; Tbakhi A; Al-Atary A; Ellsworth RE; Russell EM; Esplin ED; Horani M; Zeidan Z; Alzibdeh A; Heald B; Nielsen SM; Nussbaum RL
    JCO Glob Oncol; 2024 Jun; 10():e2400068. PubMed ID: 38843472
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
    Godley LA; DiNardo CD; Bolton K
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Cancer predisposition syndromes: lessons for truly precision medicine.
    Glaire MA; Brown M; Church DN; Tomlinson I
    J Pathol; 2017 Jan; 241(2):226-235. PubMed ID: 27859368
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Upper Gastrointestinal Cancers and the Role of Genetic Testing.
    Harrold EC; Stadler ZK
    Hematol Oncol Clin North Am; 2024 Jun; 38(3):677-691. PubMed ID: 38458854
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.
    Deyell RJ; Shen Y; Titmuss E; Dixon K; Williamson LM; Pleasance E; Nelson JMT; Abbasi S; Krzywinski M; Armstrong L; Bonakdar M; Ch'ng C; Chuah E; Dunham C; Fok A; Jones M; Lee AF; Ma Y; Moore RA; Mungall AJ; Mungall KL; Rogers PC; Schrader KA; Virani A; Wee K; Young SS; Zhao Y; Jones SJM; Laskin J; Marra MA; Rassekh SR
    Nat Commun; 2024 May; 15(1):4165. PubMed ID: 38755180
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Experiences of pediatric cancer patients (age 12-18 years) with extensive germline sequencing for cancer predisposition: a qualitative study.
    Bon SBB; Wouters RHP; Bakhuizen JJ; Jongmans MCJ; van den Heuvel-Eibrink MM; Grootenhuis MA
    Eur J Hum Genet; 2024 May; 32(5):567-575. PubMed ID: 38409533
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers.
    Hayashi N; Ono M; Fukada I; Yamazaki M; Sato N; Hosonaga M; Wang X; Kaneko K; Arakawa H; Habano E; Kuga A; Kataoka A; Ueki A; Kiyotani K; Tonooka A; Takeuchi K; Kogawa T; Kitano S; Takano T; Watanabe M; Mori S; Takahashi S
    ESMO Open; 2024 Aug; 9(8):103659. PubMed ID: 39137480
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Genetic Predisposition to Sarcoma: What Should Clinicians Know?
    Vagher J; Mehrhoff CJ; Florou V; Maese LD
    Curr Treat Options Oncol; 2024 Jun; 25(6):769-783. PubMed ID: 38713268
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Do All Patients Diagnosed With Cancer Deserve Germline Testing?
    Sorscher S
    J Clin Oncol; 2023 Aug; 41(24):4057-4058. PubMed ID: 37311151
    [No Abstract]   [Full Text] [Related]  

  • 110. A state-wide initiative to promote genetic testing in an underserved population.
    Underhill ML; Blonquist TM; Habin K; Lundquist D; Shannon K; Robinson K; Woodford ML; Boucher J
    Cancer Med; 2017 Jul; 6(7):1837-1844. PubMed ID: 28556546
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Predisposition to cancer in children and adolescents.
    Kratz CP; Jongmans MC; Cavé H; Wimmer K; Behjati S; Guerrini-Rousseau L; Milde T; Pajtler KW; Golmard L; Gauthier-Villars M; Jewell R; Duncan C; Maher ER; Brugieres L; Pritchard-Jones K; Bourdeaut F
    Lancet Child Adolesc Health; 2021 Feb; 5(2):142-154. PubMed ID: 33484663
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Breast cancer in adolescents and young adults.
    Johnson RH; Anders CK; Litton JK; Ruddy KJ; Bleyer A
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27397. PubMed ID: 30156052
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Germline susceptibility from broad genomic profiling of pediatric brain cancers.
    Mardis ER; Potter SL; Schieffer KM; Varga EA; Mathew MT; Costello HM; Wheeler G; Kelly BJ; Miller KE; Garfinkle EAR; Wilson RK; Cottrell CE
    Neurooncol Adv; 2024; 6(1):vdae099. PubMed ID: 39036440
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Patchwork Cancer Predisposition.
    Liggett LA; Sankaran VG
    Cancer Discov; 2022 Apr; 12(4):889-891. PubMed ID: 35373283
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Factors Affecting Genetic Consultation in Adolescent and Young Adult Patients With Sarcoma.
    McKay GE; Zakas AL; Osman F; Parkes A
    J Natl Compr Canc Netw; 2021 Oct; ():1-8. PubMed ID: 34666309
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort.
    Hammer-Hansen S; Stoltze U; Bartels E; Hansen TVO; Byrjalsen A; Tybjærg-Hansen A; Juul K; Schmiegelow K; Tfelt J; Bundgaard H; Wadt K; Diness BR
    Eur J Hum Genet; 2024 Jul; 32(7):846-857. PubMed ID: 38740897
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Self-reported awareness of genetic testing, the impact of family history, and access to clinical trials for people diagnosed with ovarian cancer in Australia.
    Roczo D; Alford V; Trainer A; DeFazio A; Pearn A; Delaney C; Cotter M; Hegarty S
    Gynecol Oncol Rep; 2024 Aug; 54():101427. PubMed ID: 38989471
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer:
    Subbiah V; Kurzrock R
    J Clin Oncol; 2023 Jun; 41(17):3100-3103. PubMed ID: 36930859
    [No Abstract]   [Full Text] [Related]  

  • 119. Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults.
    Brown A; Batra S
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473358
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Cancer-predisposing germline variants and subsequent cancer risk.
    Ronckers CM; Kratz CP; Berrington de Gonzalez A
    Lancet Oncol; 2023 Oct; 24(10):1059-1061. PubMed ID: 37797628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.